High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy.
Saved in:
| Title: | High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy. |
|---|---|
| Authors: | Dower K; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Zhao S; Clinical Bioinformatics, Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Schlerman FJ; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Savary L; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America., Campanholle G; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Johnson BG; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Xi L; Clinical Bioinformatics, Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Nguyen V; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America., Zhan Y; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America., Lech MP; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Wang J; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Nie Q; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America., Karsdal MA; Nordic Bioscience A/S, Herlev, Denmark., Genovese F; Nordic Bioscience A/S, Herlev, Denmark., Boucher G; Drug Safety, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America., Brown TP; Drug Safety, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America., Zhang B; Clinical Bioinformatics, Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Homer BL; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America., Martinez RV; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America. |
| Source: | PloS one [PLoS One] 2017 Jul 26; Vol. 12 (7), pp. e0181861. Date of Electronic Publication: 2017 Jul 26 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28746409 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dower+K%22">Dower K</searchLink>; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Zhao+S%22">Zhao S</searchLink>; Clinical Bioinformatics, Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Schlerman+FJ%22">Schlerman FJ</searchLink>; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Savary+L%22">Savary L</searchLink>; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Campanholle+G%22">Campanholle G</searchLink>; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Johnson+BG%22">Johnson BG</searchLink>; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Xi+L%22">Xi L</searchLink>; Clinical Bioinformatics, Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Nguyen+V%22">Nguyen V</searchLink>; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Zhan+Y%22">Zhan Y</searchLink>; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Lech+MP%22">Lech MP</searchLink>; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Nie+Q%22">Nie Q</searchLink>; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Karsdal+MA%22">Karsdal MA</searchLink>; Nordic Bioscience A/S, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Genovese+F%22">Genovese F</searchLink>; Nordic Bioscience A/S, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Boucher+G%22">Boucher G</searchLink>; Drug Safety, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America.<br /><searchLink fieldCode="AU" term="%22Brown+TP%22">Brown TP</searchLink>; Drug Safety, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America.<br /><searchLink fieldCode="AU" term="%22Zhang+B%22">Zhang B</searchLink>; Clinical Bioinformatics, Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Homer+BL%22">Homer BL</searchLink>; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Martinez+RV%22">Martinez RV</searchLink>; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2017 Jul 26; Vol. 12 (7), pp. e0181861. <i>Date of Electronic Publication: </i>2017 Jul 26 (<i>Print Publication: </i>2017). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28746409 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0181861 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0181861 Titles: – TitleFull: High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dower K – PersonEntity: Name: NameFull: Zhao S – PersonEntity: Name: NameFull: Schlerman FJ – PersonEntity: Name: NameFull: Savary L – PersonEntity: Name: NameFull: Campanholle G – PersonEntity: Name: NameFull: Johnson BG – PersonEntity: Name: NameFull: Xi L – PersonEntity: Name: NameFull: Nguyen V – PersonEntity: Name: NameFull: Zhan Y – PersonEntity: Name: NameFull: Lech MP – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Nie Q – PersonEntity: Name: NameFull: Karsdal MA – PersonEntity: Name: NameFull: Genovese F – PersonEntity: Name: NameFull: Boucher G – PersonEntity: Name: NameFull: Brown TP – PersonEntity: Name: NameFull: Zhang B – PersonEntity: Name: NameFull: Homer BL – PersonEntity: Name: NameFull: Martinez RV IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 07 Text: 2017 Jul 26 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 12 – Type: issue Value: 7 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |
